Immunic, Inc. (FRA:10VA)
Germany · Delayed Price · Currency is EUR 0.5650
-0.0050 (-0.88%)
At close: Jan 26, 2026
Immunic Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
90
Market Cap
63.28M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WASGAU Produktions & Handels AG | 653.26M |
| Nordwest Handel AG | 273.32M |
| Schwälbchen Molkerei Jakob Berz AG | 209.22M |
| capsensixx AG | 176.29M |
| InnoTec TSS AG | 117.90M |
| audius SE | 90.95M |
| learnd SE | 68.30M |
| Infas Holding AG | 63.66M |